Sort
34,240 grants matching “atherosclerosis”
Prognostic Biomarkers to Predict Progression of Pediatric Chronic Kidney Disease
$290,759Ellen Rose Brooks · Lurie Children'S Hospital Of Chicago · R01 · FY2013 · HD
Defining the role of ubiquitination in the regulation of lipid droplets
$290,728James A Olzmann · University Of California Berkeley · R00 · FY2015 · DK
CARDIOVASCULAR BIOCHEMISTRY AND ATHEROSCLEROSIS
$290,692Weill Medical College Of Cornell Univ · T32 · FY2001 · HL
Molecular mechanisms to maintain ER redox balance
$290,684Carolyn S Sevier · Cornell University · R01 · FY2017 · GM
GHB Toxicokinetics: Role of sex hormone dependent monocarboxylate transporter regulation and potential for altered overdose risk in transgender men and women
$290,624Melanie Felmlee · University Of The Pacific-Stockton · SC1 · FY2023 · DA
"A signaling integrator plays a critical role in regulating cell migration"
$290,617Donna J Webb · Vanderbilt University · R01 · FY2013 · GM
Biology and Pathologies of Type V Collagen
$290,616Daniel S Greenspan · University Of Wisconsin-Madison · R56 · FY2008 · AR
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH
$290,613Robert L Jilka · Univ Of Arkansas For Med Scis · P01 · FY2016 · AG
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH
$290,613Robert L Jilka · Univ Of Arkansas For Med Scis · P01 · FY2014 · AG
Are Cardioprotective Medications Effective in ESRD?
$290,577Theresa I. Shireman · University Of Kansas Medical Center · R01 · FY2009 · DK
ANGIOTENSIN II SIGNAL TRANSDUCTION
$290,525University Of Rochester · R01 · FY2002 · HL
STRUCTURE/FUNCTION ANALYSIS OF THE UROKINASE RECEPTOR
$290,520University Of Pennsylvania · R01 · FY2002 · HL
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease Modulation
$290,450David Y Hui · University Of Cincinnati · R01 · FY2014 · DK
LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease Modulation
$290,450David Y Hui · University Of Cincinnati · R01 · FY2012 · DK
OXIDIZED LIPIDS, BONE LOSS AND ITS REVERSAL BY INTERMITTENT PTH
$290,449Robert L Jilka · Univ Of Arkansas For Med Scis · P01 · FY2012 · AG
Novel Therapeutics for Endothelial Dysfunction
$290,425Sheau-Yu T Hsu · Adepthera, Llc · R43 · FY2017 · TR
Ascorbic Acid Function and Metabolism
$290,408James M May · Vanderbilt University · R01 · FY2007 · DK
Lipid transport in the intestine
$290,394Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2011 · DK
Neurotrophins in angiogenesis
$290,389Barbara L Hempstead · Weill Medical Coll Of Cornell Univ · P01 · FY2006 · HL
Neurotrophins in angiogenesis
$290,389Weill Medical College Of Cornell Univ · P01 · FY2005 · HL
Neurotrophins in angiogenesis
$290,389Weill Medical College Of Cornell Univ · P01 · FY2002 · HL
Neurotrophins in angiogenesis
$290,389Weill Medical College Of Cornell Univ · P01 · FY2003 · HL
Neurotrophins in angiogenesis
$290,389Weill Medical College Of Cornell Univ · P01 · FY2004 · HL
Calpain-1 Activity and Central Arterial Aging
$290,380Edward Lakatta · National Institute On Aging · ZIA · FY2013 · AG
APOE AND ATHEROGENESIS
$290,372J. David Gladstone Institutes · R01 · FY2001 · HL